CE Mark is a requirement to legally market, so is essential to Europe. Beyond that it comes down to whether the providers trust the technology and can make the logistics favourable.
I agree I think the results of the second clinical trial were quite good and people selling the news didn't appreciate how difficult differential diagnosis of these lung problems can be. Second half next year we should be in a good position to resubmit FDA.
RAP Price at posting:
9.4¢ Sentiment: Hold Disclosure: Held
